{
    "biomarkers": {
        "Hsuuy9tn": {
            "name": "Circulating tumor cells (CTCs)",
            "doc_id": "10.1038/s41598-023-42037-w",
            "llm_id": "phi4:14b/PPEkf",
            "details": {
                "name": "Circulating tumor cells (CTCs)",
                "type": "biomarker",
                "description": "Cells that have shed into the vasculature or lymphatics from a primary tumor and circulate in the bloodstream.",
                "findings": "CTCs can be isolated to study DNA methylation patterns indicative of cancer progression.",
                "notes": "Used for studying DNA methylation and identifying potential therapeutic targets.",
                "knowledge": [
                    {
                        "subject": "Circulating tumor cells (CTCs)",
                        "predicate": "are indicative of",
                        "object": "cancer progression"
                    },
                    {
                        "subject": "Circulating tumor cells (CTCs)",
                        "predicate": "can be isolated for studying",
                        "object": "DNA methylation patterns"
                    }
                ]
            }
        },
        "-WyAONR9": {
            "name": "DNA methylation",
            "doc_id": "10.1038/s41598-023-42037-w",
            "llm_id": "phi4:14b/PPEkf",
            "details": {
                "name": "DNA methylation",
                "type": "biomarker",
                "description": "An epigenetic mechanism that involves the addition of a methyl group to DNA, affecting gene expression.",
                "findings": "Distinctive DNA methylation patterns in CTCs are associated with cancer progression and can be used as biomarkers.",
                "notes": "Utilized for identifying potential therapeutic targets in colorectal cancer.",
                "knowledge": [
                    {
                        "subject": "DNA methylation",
                        "predicate": "is an epigenetic mechanism involving",
                        "object": "addition of a methyl group to DNA"
                    },
                    {
                        "subject": "DNA methylation patterns",
                        "predicate": "are associated with",
                        "object": "cancer progression"
                    }
                ]
            }
        },
        "Nxb5i5Zy": {
            "name": "Methylation sites",
            "doc_id": "10.1038/s41598-023-42037-w",
            "llm_id": "phi4:14b/PPEkf",
            "details": {
                "name": "Methylation sites",
                "type": "biomarker",
                "description": "Specific locations on the DNA where a methyl group is added, affecting gene expression.",
                "findings": "Differential methylation of these sites in CTCs can serve as biomarkers for colorectal cancer progression.",
                "notes": "Used to distinguish between different stages and subtypes of colorectal cancer.",
                "knowledge": [
                    {
                        "subject": "Methylation sites",
                        "predicate": "are specific locations on DNA affected by",
                        "object": "addition of a methyl group"
                    },
                    {
                        "subject": "Differential methylation of these sites",
                        "predicate": "can serve as biomarkers for",
                        "object": "colorectal cancer progression"
                    }
                ]
            }
        },
        "2B5VtAvL": {
            "name": "Acute phase proteins",
            "doc_id": "10.1002/anie.202306154",
            "llm_id": "phi4:14b/PPEkf",
            "details": {
                "name": "Acute phase proteins",
                "type": "Biomarkers",
                "description": "Proteins whose plasma concentrations increase (positive acute phase proteins) or decrease (negative acute phase proteins) in response to inflammation.",
                "findings": "Their concentration changes can be used as a diagnostic marker for inflammatory diseases.",
                "notes": "Acute phase proteins include CRP, serum amyloid A protein, fibrinogen, and more.",
                "knowledge": [
                    {
                        "subject": "Acute phase proteins",
                        "predicate": "are",
                        "object": "proteins whose plasma concentrations change in response to inflammation"
                    },
                    {
                        "subject": "Positive acute phase proteins",
                        "predicate": "increase",
                        "object": "plasma concentration during inflammation"
                    },
                    {
                        "subject": "Negative acute phase proteins",
                        "predicate": "decrease",
                        "object": "plasma concentration during inflammation"
                    }
                ]
            }
        },
        "PFuXdmMJ": {
            "name": "C-reactive protein (CRP)",
            "doc_id": "10.1002/anie.202306154",
            "llm_id": "phi4:14b/PPEkf",
            "details": {
                "name": "C-reactive protein (CRP)",
                "type": "Biomarker",
                "description": "A positive acute phase protein used as a diagnostic marker for inflammatory diseases.",
                "findings": "CRP levels are measured by clinical laboratories to indicate inflammation and infection.",
                "notes": "CRP is part of the innate immune system.",
                "knowledge": [
                    {
                        "subject": "C-reactive protein",
                        "predicate": "is",
                        "object": "a positive acute phase protein"
                    },
                    {
                        "subject": "CRP levels",
                        "predicate": "are measured by",
                        "object": "clinical laboratories"
                    }
                ]
            }
        },
        "MouBOm7T": {
            "name": "Serum amyloid A protein",
            "doc_id": "10.1002/anie.202306154",
            "llm_id": "phi4:14b/PPEkf",
            "details": {
                "name": "Serum amyloid A protein",
                "type": "Biomarker",
                "description": "A positive acute phase protein involved in the inflammatory response.",
                "findings": "It serves as a diagnostic marker for inflammation, similar to CRP.",
                "notes": "Its levels increase during inflammation.",
                "knowledge": [
                    {
                        "subject": "Serum amyloid A protein",
                        "predicate": "is",
                        "object": "a positive acute phase protein"
                    },
                    {
                        "subject": "Serum amyloid A protein",
                        "predicate": "serves as",
                        "object": "a diagnostic marker for inflammation"
                    }
                ]
            }
        },
        "nIV_R995": {
            "name": "Fibrinogen",
            "doc_id": "10.1002/anie.202306154",
            "llm_id": "phi4:14b/PPEkf",
            "details": {
                "name": "Fibrinogen",
                "type": "Biomarker",
                "description": "A glycoprotein that plays a role in blood clotting and is also an acute phase protein.",
                "findings": "Fibrinogen levels rise during inflammatory responses, aiding in diagnosis.",
                "notes": "It is part of the positive acute phase proteins.",
                "knowledge": [
                    {
                        "subject": "Fibrinogen",
                        "predicate": "is",
                        "object": "a glycoprotein and an acute phase protein"
                    },
                    {
                        "subject": "Fibrinogen levels",
                        "predicate": "rise during",
                        "object": "inflammatory responses"
                    }
                ]
            }
        },
        "8Za2oY7f": {
            "name": "Protein C",
            "doc_id": "10.1002/anie.202306154",
            "llm_id": "phi4:14b/PPEkf",
            "details": {
                "name": "Protein C",
                "type": "Biomarker",
                "description": "A vitamin K-dependent protein involved in the regulation of blood coagulation and inflammation.",
                "findings": "Its concentration changes during inflammatory conditions, providing diagnostic insights.",
                "notes": "It is one of the acute phase proteins measured for inflammation.",
                "knowledge": [
                    {
                        "subject": "Protein C",
                        "predicate": "is involved in",
                        "object": "the regulation of blood coagulation and inflammation"
                    },
                    {
                        "subject": "Protein C concentration",
                        "predicate": "changes during",
                        "object": "inflammatory conditions"
                    }
                ]
            }
        },
        "Ka6tBgmo": {
            "name": "Lipoprotein (a)",
            "doc_id": "10.1002/anie.202306154",
            "llm_id": "phi4:14b/PPEkf",
            "details": {
                "name": "Lipoprotein (a)",
                "type": "Biomarker",
                "description": "A low-density lipoprotein variant associated with increased risk of cardiovascular diseases.",
                "findings": "Levels can indicate inflammation and are used in diagnostics for related conditions.",
                "notes": "It is considered an acute phase protein.",
                "knowledge": [
                    {
                        "subject": "Lipoprotein (a)",
                        "predicate": "is",
                        "object": "a low-density lipoprotein variant"
                    },
                    {
                        "subject": "Lipoprotein (a) levels",
                        "predicate": "indicate",
                        "object": "inflammation"
                    }
                ]
            }
        },
        "l6O4SdJp": {
            "name": "Alpha-1-antitrypsin",
            "doc_id": "10.1002/anie.202306154",
            "llm_id": "phi4:14b/PPEkf",
            "details": {
                "name": "Alpha-1-antitrypsin",
                "type": "Biomarker",
                "description": "A protease inhibitor that protects tissues from enzymes of inflammatory cells.",
                "findings": "Its levels are indicative of inflammation and used in diagnostic tests.",
                "notes": "It is another acute phase protein involved in the immune response.",
                "knowledge": [
                    {
                        "subject": "Alpha-1-antitrypsin",
                        "predicate": "is",
                        "object": "a protease inhibitor"
                    },
                    {
                        "subject": "Alpha-1-antitrypsin levels",
                        "predicate": "are indicative of",
                        "object": "inflammation"
                    }
                ]
            }
        },
        "tS3cr6ZG": {
            "name": "Haptoglobin",
            "doc_id": "10.1002/anie.202306154",
            "llm_id": "phi4:14b/PPEkf",
            "details": {
                "name": "Haptoglobin",
                "type": "Biomarker",
                "description": "A protein that binds free hemoglobin released from erythrocytes, playing a role in inflammation.",
                "findings": "Its concentration increases during inflammatory responses, aiding diagnosis.",
                "notes": "It is part of the positive acute phase proteins.",
                "knowledge": [
                    {
                        "subject": "Haptoglobin",
                        "predicate": "binds free hemoglobin"
                    },
                    {
                        "subject": "Haptoglobin concentration",
                        "predicate": "increases during",
                        "object": "inflammatory responses"
                    }
                ]
            }
        },
        "hO_4-wq3": {
            "name": "Alpha-1-acid glycoprotein",
            "doc_id": "10.1002/anie.202306154",
            "llm_id": "phi4:14b/PPEkf",
            "details": {
                "name": "Alpha-1-acid glycoprotein",
                "type": "Biomarker",
                "description": "A serum protein with immunomodulatory and anti-inflammatory properties.",
                "findings": "Its levels rise during inflammation, providing diagnostic information.",
                "notes": "It is an acute phase reactant measured in inflammatory conditions.",
                "knowledge": [
                    {
                        "subject": "Alpha-1-acid glycoprotein",
                        "predicate": "has",
                        "object": "immunomodulatory and anti-inflammatory properties"
                    },
                    {
                        "subject": "Alpha-1-acid glycoprotein levels",
                        "predicate": "rise during",
                        "object": "inflammation"
                    }
                ]
            }
        },
        "qLU5wf-C": {
            "name": "Ferritin",
            "doc_id": "10.1002/anie.202306154",
            "llm_id": "phi4:14b/PPEkf",
            "details": {
                "name": "Ferritin",
                "type": "Biomarker",
                "description": "A protein that stores iron and releases it in a controlled fashion, involved in inflammation.",
                "findings": "Its levels increase during inflammation, serving as a diagnostic marker.",
                "notes": "It is part of the acute phase proteins.",
                "knowledge": [
                    {
                        "subject": "Ferritin",
                        "predicate": "stores iron"
                    },
                    {
                        "subject": "Ferritin levels",
                        "predicate": "increase during",
                        "object": "inflammation"
                    }
                ]
            }
        },
        "xbTmLMww": {
            "name": "Neutrophil gelatinase-associated lipocalin (NGAL)",
            "doc_id": "10.1002/anie.202306154",
            "llm_id": "phi4:14b/PPEkf",
            "details": {
                "name": "Neutrophil gelatinase-associated lipocalin (NGAL)",
                "type": "Biomarker",
                "description": "A protein associated with kidney injury and inflammation.",
                "findings": "Its levels are measured to assess inflammatory conditions and renal function.",
                "notes": "It is an acute phase reactant used in diagnostics.",
                "knowledge": [
                    {
                        "subject": "NGAL",
                        "predicate": "is associated with",
                        "object": "kidney injury and inflammation"
                    },
                    {
                        "subject": "NGAL levels",
                        "predicate": "are measured to assess",
                        "object": "inflammatory conditions and renal function"
                    }
                ]
            }
        },
        "jTfB9wEN": {
            "name": "miR-126",
            "doc_id": "10.3390/cancers13184640",
            "llm_id": "phi4:14b/PPEkf",
            "details": {
                "name": "miR-126",
                "type": "microRNA",
                "description": "A microRNA included in the CEx-miRNAs panel for early CRC diagnosis and prognosis.",
                "findings": "miR-126 has shown promising predictive data for early CRC stages as part of a biomarker panel.",
                "notes": "Part of a CEx-miRNAs panel used for minimally invasive detection methods like blood samples (serum).",
                "knowledge": [
                    {
                        "subject": "miR-126",
                        "predicate": "has shown",
                        "object": "promising predictive data"
                    },
                    {
                        "subject": "miR-126",
                        "predicate": "is included in",
                        "object": "CEx-miRNAs panel"
                    }
                ]
            }
        },
        "3zl2epy1": {
            "name": "miR-1290",
            "doc_id": "10.3390/cancers13184640",
            "llm_id": "phi4:14b/PPEkf",
            "details": {
                "name": "miR-1290",
                "type": "microRNA",
                "description": "A microRNA included in the CEx-miRNAs panel for early CRC diagnosis and prognosis.",
                "findings": "miR-1290 has shown promising predictive data for early CRC stages as part of a biomarker panel.",
                "notes": "Part of a CEx-miRNAs panel used for minimally invasive detection methods like blood samples (serum).",
                "knowledge": [
                    {
                        "subject": "miR-1290",
                        "predicate": "has shown",
                        "object": "promising predictive data"
                    },
                    {
                        "subject": "miR-1290",
                        "predicate": "is included in",
                        "object": "CEx-miRNAs panel"
                    }
                ]
            }
        },
        "7NRcKQYJ": {
            "name": "miR-23a",
            "doc_id": "10.3390/cancers13184640",
            "llm_id": "phi4:14b/PPEkf",
            "details": {
                "name": "miR-23a",
                "type": "microRNA",
                "description": "A microRNA included in the CEx-miRNAs panel for early CRC diagnosis and prognosis.",
                "findings": "miR-23a has shown promising predictive data for early CRC stages as part of a biomarker panel.",
                "notes": "Part of a CEx-miRNAs panel used for minimally invasive detection methods like blood samples (serum).",
                "knowledge": [
                    {
                        "subject": "miR-23a",
                        "predicate": "has shown",
                        "object": "promising predictive data"
                    },
                    {
                        "subject": "miR-23a",
                        "predicate": "is included in",
                        "object": "CEx-miRNAs panel"
                    }
                ]
            }
        },
        "r36DcCzK": {
            "name": "miR-940",
            "doc_id": "10.3390/cancers13184640",
            "llm_id": "phi4:14b/PPEkf",
            "details": {
                "name": "miR-940",
                "type": "microRNA",
                "description": "A microRNA included in the CEx-miRNAs panel for early CRC diagnosis and prognosis.",
                "findings": "miR-940 has shown promising predictive data for early CRC stages as part of a biomarker panel.",
                "notes": "Part of a CEx-miRNAs panel used for minimally invasive detection methods like blood samples (serum).",
                "knowledge": [
                    {
                        "subject": "miR-940",
                        "predicate": "has shown",
                        "object": "promising predictive data"
                    },
                    {
                        "subject": "miR-940",
                        "predicate": "is included in",
                        "object": "CEx-miRNAs panel"
                    }
                ]
            }
        },
        "kacKc5ic": {
            "name": "MSI-H",
            "doc_id": "10.3390/cancers16162796",
            "llm_id": "phi4:14b/PPEkf",
            "details": {
                "name": "MSI-H",
                "type": "Genetic Mutation",
                "description": "Microsatellite instability-high status in colorectal cancer.",
                "findings": "Confers substantial improvements in clinical outcomes and decreased toxicities through immune checkpoint inhibitors (ICI).",
                "notes": "Predictive of the response to ICI, offering patients long-term survival or near curative results.",
                "knowledge": [
                    {
                        "subject": "MSI-H",
                        "predicate": "confers",
                        "object": "substantial improvements in clinical outcomes and decreased toxicities"
                    },
                    {
                        "subject": "MSI-H",
                        "predicate": "is predictive of",
                        "object": "response to immune checkpoint inhibitors (ICI)"
                    }
                ]
            }
        },
        "Z8XWYP1A": {
            "name": "RAS",
            "doc_id": "10.3390/cancers16162796",
            "llm_id": "phi4:14b/PPEkf",
            "details": {
                "name": "RAS",
                "type": "Genetic Mutation",
                "description": "A family of genes involved in cellular signal transduction.",
                "findings": "Has necessitated a molecular-targeted approach in colorectal cancer (CRC).",
                "notes": "Part of the predictive biomarker landscape for targeted therapies in CRC.",
                "knowledge": [
                    {
                        "subject": "RAS",
                        "predicate": "necessitates",
                        "object": "molecular-targeted approach in CRC"
                    }
                ]
            }
        },
        "FrklqUIz": {
            "name": "BRAF V600E",
            "doc_id": "10.3390/cancers16162796",
            "llm_id": "phi4:14b/PPEkf",
            "details": {
                "name": "BRAF V600E",
                "type": "Genetic Mutation",
                "description": "A specific mutation in the BRAF gene, associated with poor prognosis.",
                "findings": "Predictive of response to combined targeted BRAF/EGFR inhibition, doubling survival over standard treatments.",
                "notes": "Previously had a negative prognostic value but now serves as a predictive biomarker for certain therapies.",
                "knowledge": [
                    {
                        "subject": "BRAF V600E",
                        "predicate": "is predictive of",
                        "object": "response to combined targeted BRAF/EGFR inhibition"
                    },
                    {
                        "subject": "BRAF V600E",
                        "predicate": "doubles survival over",
                        "object": "standard treatments"
                    }
                ]
            }
        },
        "T3m9GGr2": {
            "name": "KRAS",
            "doc_id": "10.3390/cancers16162796",
            "llm_id": "phi4:14b/PPEkf",
            "details": {
                "name": "KRAS",
                "type": "Genetic Mutation",
                "description": "A gene involved in cellular signal transduction pathways.",
                "findings": "Reprograms cellular metabolism, making KRAS-mutant tumors more susceptible to ferroptosis induction as a potential clinical strategy.",
                "notes": "Influence on glutamine metabolism and susceptibility to targeted therapies like ferroptosis induction.",
                "knowledge": [
                    {
                        "subject": "KRAS",
                        "predicate": "reprograms",
                        "object": "cellular metabolism"
                    },
                    {
                        "subject": "KRAS-mutant tumors",
                        "predicate": "are more susceptible to",
                        "object": "ferroptosis induction"
                    }
                ]
            }
        },
        "j24tCP7u": {
            "name": "Ferroptosis",
            "doc_id": "10.3390/cancers16162796",
            "llm_id": "phi4:14b/PPEkf",
            "details": {
                "name": "Ferroptosis",
                "type": "Cell Death Mechanism",
                "description": "A form of regulated cell death distinct from apoptosis and necrosis.",
                "findings": "Explored in combination therapy with immune checkpoint inhibitors (ICIs) as a promising strategy to increase sensitivity and overcome resistance.",
                "notes": "Related to glutamine metabolism, particularly through the synthesis of glutathione (GSH) and glutaminolysis.",
                "knowledge": [
                    {
                        "subject": "Ferroptosis",
                        "predicate": "is explored in combination therapy with",
                        "object": "immune checkpoint inhibitors (ICIs)"
                    },
                    {
                        "subject": "Ferroptosis",
                        "predicate": "increases sensitivity and overcomes",
                        "object": "resistance"
                    }
                ]
            }
        },
        "32OeLRkN": {
            "name": "Glutamine Metabolism",
            "doc_id": "10.3390/cancers16162796",
            "llm_id": "phi4:14b/PPEkf",
            "details": {
                "name": "Glutamine Metabolism",
                "type": "Metabolic Pathway",
                "description": "A metabolic process involving the synthesis of glutathione (GSH) and through glutaminolysis.",
                "findings": "Regulates ferroptosis, contributing to the susceptibility of KRAS-mutant tumors to therapeutic strategies.",
                "notes": "Key in the context of ferroptosis and its potential use in cancer treatment strategies.",
                "knowledge": [
                    {
                        "subject": "Glutamine metabolism",
                        "predicate": "regulates",
                        "object": "ferroptosis"
                    },
                    {
                        "subject": "Glutamine metabolism",
                        "predicate": "contributes to",
                        "object": "susceptibility of KRAS-mutant tumors"
                    }
                ]
            }
        },
        "PwvzHKxN": {
            "name": "Gefitinib",
            "doc_id": "10.1126/sciadv.aaw1317",
            "llm_id": "phi4:14b/PPEkf",
            "details": {
                "name": "Gefitinib",
                "type": "drug",
                "description": "An epidermal growth factor receptor tyrosine kinase inhibitor used to treat certain cancers.",
                "findings": "Gefitinib was tested for its ability to prevent proliferation of cancer cells in a 3D tumor model.",
                "notes": "The study explored the effect of Gefitinib on EGFR mutant lung adenocarcinoma cells.",
                "knowledge": [
                    {
                        "subject": "Gefitinib",
                        "predicate": "tested for its ability to prevent proliferation",
                        "object": "cancer cells in a 3D tumor model"
                    }
                ]
            }
        },
        "h_e8JIju": {
            "name": "EGFR mutant lung adenocarcinoma cells",
            "doc_id": "10.1126/sciadv.aaw1317",
            "llm_id": "phi4:14b/PPEkf",
            "details": {
                "name": "EGFR mutant lung adenocarcinoma cells",
                "type": "biomarker/type of cancer cell",
                "description": "Cells with mutations in the epidermal growth factor receptor involved in lung adenocarcinoma.",
                "findings": "These cells were shown to be less responsive to Gefitinib when grown as multicellular aggregates compared to monolayers.",
                "notes": "This finding highlights the complexity of drug response in different cellular environments.",
                "knowledge": [
                    {
                        "subject": "EGFR mutant lung adenocarcinoma cells",
                        "predicate": "were shown to be less responsive to",
                        "object": "Gefitinib when grown as multicellular aggregates"
                    }
                ]
            }
        },
        "USh19xCZ": {
            "name": "3D tumor model",
            "doc_id": "10.1126/sciadv.aaw1317",
            "llm_id": "phi4:14b/PPEkf",
            "details": {
                "name": "3D tumor model",
                "type": "experimental setup",
                "description": "A model that mimics the three-dimensional structure of a tumor for research purposes.",
                "findings": "The 3D tumor model was used to evaluate the efficacy of Gefitinib on cancer cells.",
                "notes": "This model provides a more realistic environment compared to traditional two-dimensional cell cultures.",
                "knowledge": [
                    {
                        "subject": "3D tumor model",
                        "predicate": "was used to evaluate",
                        "object": "the efficacy of Gefitinib on cancer cells"
                    }
                ]
            }
        },
        "XG6YGDnb": {
            "name": "Cellular aggregates (multicellular spheroids)",
            "doc_id": "10.1126/sciadv.aaw1317",
            "llm_id": "phi4:14b/PPEkf",
            "details": {
                "name": "Cellular aggregates (multicellular spheroids)",
                "type": "biomarker/experimental condition",
                "description": "Clusters of cells that form three-dimensional structures used in biological research.",
                "findings": "Cells grown as multicellular aggregates exhibited different responses to Gefitinib than when grown in monolayers.",
                "notes": "This indicates the importance of cellular architecture in drug response studies.",
                "knowledge": [
                    {
                        "subject": "Cellular aggregates (multicellular spheroids)",
                        "predicate": "exhibited different responses to",
                        "object": "Gefitinib than when grown in monolayers"
                    }
                ]
            }
        },
        "SGoDLgVK": {
            "name": "Monolayer cultures",
            "doc_id": "10.1126/sciadv.aaw1317",
            "llm_id": "phi4:14b/PPEkf",
            "details": {
                "name": "Monolayer cultures",
                "type": "experimental condition",
                "description": "A method of growing cells in a single layer, commonly used in biological research.",
                "findings": "Cells grown in monolayers responded differently to Gefitinib compared to those in multicellular aggregates.",
                "notes": "The difference highlights the limitations of traditional 2D cultures in mimicking tumor environments.",
                "knowledge": [
                    {
                        "subject": "Monolayer cultures",
                        "predicate": "cells grown in responded differently to",
                        "object": "Gefitinib compared to multicellular aggregates"
                    }
                ]
            }
        },
        "fJXam3Q9": {
            "name": "Drug resistance",
            "doc_id": "10.1126/sciadv.aaw1317",
            "llm_id": "phi4:14b/PPEkf",
            "details": {
                "name": "Drug resistance",
                "type": "biomarker/phenomenon",
                "description": "The reduction in effectiveness of a drug such as an antimicrobial or an antineoplastic in curing a disease.",
                "findings": "Multicellular aggregates demonstrated increased resistance to Gefitinib compared to monolayer cultures.",
                "notes": "Understanding the mechanisms behind this resistance is crucial for improving cancer treatment strategies.",
                "knowledge": [
                    {
                        "subject": "Drug resistance",
                        "predicate": "was demonstrated in multicellular aggregates",
                        "object": "compared to monolayer cultures"
                    }
                ]
            }
        },
        "P-izvtM4": {
            "name": "Guanylate cyclase-C (GCC)",
            "doc_id": "10.1001/jamaoncol.2024.3891",
            "llm_id": "phi4:14b/PPEkf",
            "details": {
                "name": "Guanylate cyclase-C (GCC)",
                "type": "Protein",
                "description": "A protein targeted by chimeric antigen receptor in the treatment of metastatic colorectal cancer.",
                "findings": "Chimeric antigen receptors targeting GCC showed efficacy and safety, resulting in partial responses in patients with metastatic colorectal cancer.",
                "notes": "Immunohistochemistry data for GCC was performed and interpreted as part of the study.",
                "knowledge": [
                    {
                        "subject": "Guanylate cyclase-C",
                        "predicate": "is targeted by",
                        "object": "chimeric antigen receptors"
                    },
                    {
                        "subject": "Chimeric antigen receptor targeting Guanylate cyclase-C",
                        "predicate": "showed efficacy and safety in",
                        "object": "treatment of metastatic colorectal cancer"
                    }
                ]
            }
        },
        "IBY9P161": {
            "name": "hCRISPRs",
            "doc_id": "10.1038/s42003-022-03249-4",
            "llm_id": "phi4:14b/PPEkf",
            "details": {
                "name": "hCRISPRs",
                "type": "transcriptional biomarkers",
                "description": "Human CRISPR-like sequences involved in transcription regulation and diagnostics.",
                "findings": "The study aimed to detect and validate hCRISPRs for their roles in transcription and diagnostics.",
                "notes": "hCRISPRs are part of the research into CRISPR-Cas-related patents.",
                "knowledge": [
                    {
                        "subject": "hCRISPRs",
                        "predicate": "are detected and validated for",
                        "object": "roles in transcription and diagnostics"
                    },
                    {
                        "subject": "R.L., C.S.",
                        "predicate": "declare competing interests related to",
                        "object": "hCRISPRs"
                    }
                ]
            }
        },
        "smNCkWzE": {
            "name": "acetone",
            "doc_id": "10.3390/ijms24010129",
            "llm_id": "phi4:14b/PPEkf",
            "details": {
                "name": "acetone",
                "type": "VOC (Volatile Organic Compound)",
                "description": "A compound with an abnormal fruity odor in breath.",
                "findings": "Acetone concentration changes during activities such as exercising or fasting, limiting its use as a cancer biomarker.",
                "notes": "Its variability due to external factors affects its reliability for cancer detection.",
                "knowledge": [
                    {
                        "subject": "acetone",
                        "predicate": "changes during",
                        "object": "exercising or fasting"
                    },
                    {
                        "subject": "acetone",
                        "predicate": "has an",
                        "object": "abnormal fruity odor"
                    }
                ]
            }
        },
        "tfkIL0df": {
            "name": "4-heptanone",
            "doc_id": "10.3390/ijms24010129",
            "llm_id": "phi4:14b/PPEkf",
            "details": {
                "name": "4-heptanone",
                "type": "VOC (Volatile Organic Compound)",
                "description": "A compound with unclear origins.",
                "findings": "Not recommended for use as biomarkers due to unclear origins and limited research.",
                "notes": "Its application is constrained by the lack of understanding of its production sources in the body.",
                "knowledge": [
                    {
                        "subject": "4-heptanone",
                        "predicate": "has unclear",
                        "object": "origins"
                    },
                    {
                        "subject": "4-heptanone",
                        "predicate": "is not recommended for use as",
                        "object": "biomarkers"
                    }
                ]
            }
        },
        "yKIJnm7G": {
            "name": "VOCs (general)",
            "doc_id": "10.3390/ijms24010129",
            "llm_id": "phi4:14b/PPEkf",
            "details": {
                "name": "VOCs (general)",
                "type": "Biomarker category",
                "description": "Compounds in exhaled breath containing valuable information about cancer metabolism.",
                "findings": "Analyzing VOCs can reduce the need for invasive tests and assist early cancer detection.",
                "notes": "Advanced instruments like SIFT-MS, combined with machine learning, enhance the prediction accuracy of cancer using VOCs.",
                "knowledge": [
                    {
                        "subject": "VOCs",
                        "predicate": "contain",
                        "object": "information about cancer metabolism"
                    },
                    {
                        "subject": "analyzing VOCs",
                        "predicate": "can reduce",
                        "object": "the need for invasive tests"
                    },
                    {
                        "subject": "SIFT-MS combined with machine learning",
                        "predicate": "enhances the prediction accuracy of",
                        "object": "cancer using VOCs"
                    }
                ]
            }
        },
        "uhuZZlsJ": {
            "name": "microbiome biomarkers",
            "doc_id": "10.1111/j.2517-6161.1982.tb01195.x",
            "llm_id": "phi4:14b/PPEkf",
            "details": {
                "name": "microbiome biomarkers",
                "type": "biological",
                "description": "Specific markers within the microbiome that can differentiate between healthy and diseased states, particularly in colorectal cancer.",
                "findings": "The study identified specific microbiome biomarkers using XAI methods to aid in distinguishing colorectal cancer.",
                "notes": "Biomarkers were analyzed with publicly available datasets from Zenodo repository and GitHub.",
                "knowledge": [
                    {
                        "subject": "microbiome biomarkers",
                        "predicate": "identified",
                        "object": "using XAI methods"
                    },
                    {
                        "subject": "microbiome biomarkers",
                        "predicate": "aid in distinguishing",
                        "object": "colorectal cancer"
                    }
                ]
            }
        },
        "NBtHtki4": {
            "name": "VOCs",
            "doc_id": "10.1002/ijc.29701",
            "llm_id": "phi4:14b/PPEkf",
            "details": {
                "name": "VOCs",
                "type": "Biomarkers",
                "description": "Volatilomic markers identified in exhaled breath using sensor technology for CRC detection.",
                "findings": "Sensor technology with VOC detection shows comparable or better accuracy than the FIT test for CRC and precancerous lesion detection.",
                "notes": "The study found specific VOCs such as alkenes, alcohols, ketones, and esters in CRC patients' breath.",
                "knowledge": [
                    {
                        "subject": "VOCs",
                        "predicate": "were detected",
                        "object": "in exhaled breath"
                    },
                    {
                        "subject": "VOC detection",
                        "predicate": "has",
                        "object": "85% sensitivity and 94% specificity for cancer"
                    },
                    {
                        "subject": "sensor technology",
                        "predicate": "discriminated between",
                        "object": "CRC patients and controls with high accuracy"
                    }
                ]
            }
        },
        "Zd18UHha": {
            "name": "Acetone",
            "doc_id": "10.1002/ijc.29701",
            "llm_id": "phi4:14b/PPEkf",
            "details": {
                "name": "Acetone",
                "type": "Volatile Organic Compound (VOC)",
                "description": "A secondary product of lipid peroxidation, associated with ketosis.",
                "findings": "Elevated in CRC patients' breath due to high oxidation rates of fatty acids.",
                "notes": "Related to the metabolism and oxidative stress processes.",
                "knowledge": [
                    {
                        "subject": "Acetone",
                        "predicate": "is related to",
                        "object": "ketones family"
                    },
                    {
                        "subject": "Acetone",
                        "predicate": "forms under metabolic conditions associated with",
                        "object": "high oxidation rate of fatty acids"
                    }
                ]
            }
        },
        "NQSTHwzb": {
            "name": "Alcohols",
            "doc_id": "10.1002/ijc.29701",
            "llm_id": "phi4:14b/PPEkf",
            "details": {
                "name": "Alcohols",
                "type": "Volatile Organic Compound (VOC)",
                "description": "Derive from food, alcohol beverages, and metabolism by cytochrome p450 enzymes.",
                "findings": "Presence in breath due to food intake and metabolic processes.",
                "notes": "Contribute to the VOC profile in exhaled breath.",
                "knowledge": [
                    {
                        "subject": "Alcohols",
                        "predicate": "originate from",
                        "object": "food and alcohol beverages"
                    },
                    {
                        "subject": "Alcohols",
                        "predicate": "are derived from metabolism of hydrocarbons by",
                        "object": "cytochrome p450 enzymes"
                    }
                ]
            }
        },
        "IISXu2wo": {
            "name": "Esters",
            "doc_id": "10.1002/ijc.29701",
            "llm_id": "phi4:14b/PPEkf",
            "details": {
                "name": "Esters",
                "type": "Volatile Organic Compound (VOC)",
                "description": "Compounds found in natural sources such as fats, oils, waxes, and fruits.",
                "findings": "Detected in CRC patients' breath contributing to VOC profile.",
                "notes": "Part of the diverse range of compounds identified through sensor technology.",
                "knowledge": [
                    {
                        "subject": "Esters",
                        "predicate": "can be found in large amounts in",
                        "object": "natural sources such as fats and fatty oils, waxes, and fruit ethers"
                    }
                ]
            }
        },
        "-QSGIgAY": {
            "name": "T-antigen",
            "doc_id": "10.3390/ijms25073722",
            "llm_id": "phi4:14b/PPEkf",
            "details": {
                "name": "T-antigen",
                "type": "Glycan Biomarker",
                "description": "A cancer-associated glycan marker indicative of abnormal immature glycan signatures in aggressive lesions.",
                "findings": "Stools from more aggressive lesions exhibit abnormal immature T-antigen glycan signatures not seen in healthy tissues.",
                "notes": "Potential for non-invasive cancer diagnostics; exploratory nature limits robustness.",
                "knowledge": [
                    {
                        "subject": "T-antigen",
                        "predicate": "exhibit",
                        "object": "abnormal immature glycan signatures"
                    },
                    {
                        "subject": "Stools from more aggressive lesions",
                        "predicate": "may have",
                        "object": "abnormal immature T-antigen glycan signatures"
                    }
                ]
            }
        },
        "9PCUhYzT": {
            "name": "Stool Glycoproteome",
            "doc_id": "10.3390/ijms25073722",
            "llm_id": "phi4:14b/PPEkf",
            "details": {
                "name": "Stool Glycoproteome",
                "type": "Proteomic Biomarker",
                "description": "Characterization of molecular targets in stool that are shared by aggressive non-cancerous lesions and cancer.",
                "findings": "Identifies several molecular targets shared by more aggressive non-cancerous lesions and cancer, which hold promise for future pre-clinical assessment.",
                "notes": "Provides a framework for addressing glycosylation alterations; requires screening larger patient cohorts.",
                "knowledge": [
                    {
                        "subject": "Stool Glycoproteome",
                        "predicate": "characterize",
                        "object": "molecular targets"
                    },
                    {
                        "subject": "Molecular targets",
                        "predicate": "shared by",
                        "object": "aggressive non-cancerous lesions and cancer"
                    }
                ]
            }
        }
    },
    "documents": {
        "10.1038/s41598-023-42037-w": {
            "doi": "10.1038/s41598-023-42037-w",
            "short_citation": "(Bao-Caamano;2023)",
            "long_citation": "Bao-Caamano, et al., Epigenomic analysis reveals a unique DNA methylation program of metastasis-competent circulating tumor cells in colorectal cancer, , 2023"
        },
        "10.1002/anie.202306154": {
            "doi": "10.1002/anie.202306154",
            "short_citation": "(Saraei;2019)",
            "long_citation": "Saraei, et al., Towards a Precise NMR Quantification of Acute Phase Inflammation Proteins from Human Serum, , 2019"
        },
        "10.3390/cancers13184640": {
            "doi": "10.3390/cancers13184640",
            "short_citation": "(Dur\u00e1n-Vin;2021-09-16)",
            "long_citation": "Dur\u00e1n-Vin, et al., CRISPR/Cas13-Based Platforms for a Potential Next-Generation Diagnosis of Colorectal Cancer through Exosomes Micro-RNA Detection: A Review, , 2021-09-16"
        },
        "10.3390/cancers16162796": {
            "doi": "10.3390/cancers16162796",
            "short_citation": "(Ashouri;2024-08-08)",
            "long_citation": "Ashouri, et al., Exploring Predictive and Prognostic Biomarkers in Colorectal Cancer: A Comprehensive Review, , 2024-08-08"
        },
        "10.1126/sciadv.aaw1317": {
            "doi": "10.1126/sciadv.aaw1317",
            "short_citation": "(Carvalho;2024-12-04)",
            "long_citation": "Carvalho, et al., Colorectal tumor-on-a-chip system: A 3D tool for precision onco-nanomedicine, , 2024-12-04"
        },
        "10.1001/jamaoncol.2024.3891": {
            "doi": "10.1001/jamaoncol.2024.3891",
            "short_citation": "(Chen;2024-09-19)",
            "long_citation": "Chen, et al., Chimeric Antigen Receptor T Cells Targeting CD19 and GCC in Metastatic Colorectal Cancer A Nonrandomized Clinical Trial, , 2024-09-19"
        },
        "10.1038/s42003-022-03249-4": {
            "doi": "10.1038/s42003-022-03249-4",
            "short_citation": "(Van Riet;1989)",
            "long_citation": "Van Riet, et al., CRISPRs in the human genome are differentially expressed between malignant and normal adjacent to tumor tissue, , 1989"
        },
        "10.3390/ijms24010129": {
            "doi": "10.3390/ijms24010129",
            "short_citation": "(Chen;2022-12-21)",
            "long_citation": "Chen, et al., Diagnosis by Volatile Organic Compounds in Exhaled Breath from Patients with Gastric and Colorectal Cancers, , 2022-12-21"
        },
        "10.1111/j.2517-6161.1982.tb01195.x": {
            "doi": "10.1111/j.2517-6161.1982.tb01195.x",
            "short_citation": "(D'elia;1982)",
            "long_citation": "D'elia, et al., Explainable artificial intelligence for microbiome data analysis in colorectal cancer biomarker identification, , 1982"
        },
        "10.1002/ijc.29701": {
            "doi": "10.1002/ijc.29701",
            "short_citation": "(Amal;2015)",
            "long_citation": "Amal, et al., Breath testing as potential colorectal cancer screening tool, , 2015"
        },
        "10.3390/ijms25073722": {
            "doi": "10.3390/ijms25073722",
            "short_citation": "(Kuppen;2024-03-27)",
            "long_citation": "Kuppen, et al., Stool Glycoproteomics Signatures of Pre-Cancerous Lesions and Colorectal Cancer, , 2024-03-27"
        }
    },
    "lang_info": {
        "phi4:14b/PPEkf": {
            "llm_tag": "phi4:14b",
            "prompt_template": "[BEGIN ARTICLE]:<content></content>\n[END ARTICLE]\n\n[INSTRUCTIONS]\nGenerate list of biomarkers that are topic of the article and for each such biomarker extract name, description, type, findings explicitly mentioned in the article, and list of knowledge.\nThe list of knowledge that are from finding and that can be expressed in terms: 'subject' which is the biomarker, 'predicate' which is some verb optionally with some adverb and 'object'.\nReturn the response in strict JSON format with the following structure:\n\n[\n  { \"name\": \"biomarker name\",\"type\":\"biomarker type\",\"description\":\"biomarker description\",\"findings\":\"brief findings about biomarker in article as one sentence\",\"notes\":\"additional notes important to biomarker\", \"knowledge\":[{'subject':'repeated biomarker name','predicate':'some predicate from findings of biomarker','object':'object that relates via predicate to the biomarker' }],\n  { \"name\": \"biomarker2 name\",\"type\":\"biomarker2 type\",\"description\":\"biomarker2 description\",\"findings\":\"brief findings about biomarker2 in article as one sentence\",\"notes\":\"additional notes important to biomarker2\", \"knowledge\":[{'subject':'repeated biomarker2 name','predicate':'some predicate from findings of  biomarker2','object':'object that relates via predicate to the biomarker2' }] }\n] \n\nEnsure there is no additional explanation, only return valid JSON.\n"
        }
    }
}